Clinical Trial: Phase I/II Study of SCTB39-1 in Advanced Solid Tumours

U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050641) titled 'Phase I/II Study of SCTB39-1 in Advanced Solid Tumours' on June 25.

Brief Summary: This study aims to evaluate the safety, tolerability, PK characteristics, immunogenicity, and preliminary anti-tumor efficacy of SCTB39-1 as a monotherapy in adult patients with advanced malignant solid tumours. This study is an open label, multicentre, dose-escalation and dose-expansion Phase I/II clinical trial.

Study Start Date: June 23

Study Type: INTERVENTIONAL

Condition: Advanced Malignant Solid Tumor

Intervention: DRUG: SCTB39-1

SCTB39-1, IV

Recruitment Status: RECRUITING

Sponsor: Sinocelltech Ltd.

Disclaimer: Curated by HT Syndication...